We’re excited to share the newest edition of our flagship journal, The Chronicle!
Inside, you’ll find our overview of noteworthy research studies from the last quarter, including:
- A Genetic Risk Score for ME/CFS
- Identifying Soluble Biomarkers That Associate with Distinct Manifestations of Long Covid
- Chronic Inflammation Raises IL-6 to Drive Neurobehavioral Symptoms via Dopamine Disruption
- A Simple Hearing Test to Measure Cognitive Decline in People with Long Covid
- Endogenous Retrovirus Activation in ME/CFS, Fibromyalgia, and a Newly Discovered, Related Disease
- How COVID and Long Covid Damage Lung Tissues, and a Drug to Reverse This Damage
- Our July 22 Webinar on the ADDRESS-LC Trial
Plus, our new online guide to current clinical trials!
To read the Summer 2025 Chronicle, click here.
Read previous issues of The Chronicle here.
To have the next print edition delivered free of charge by mail to your home or business, click here.